GNVR.US GNVR
- Market cap
- USD 27.3M
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is GNVR.US undervalued?
Graham numberThe Graham number of GNVR cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
GNVR fundamental analysis
No fundamental analysis for GNVR yet.
GNVR stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About GNVR
Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canlab International for the development, manufacturing, and com…
Full company profileFinancial statements of GNVR are not available yet.
GNVR dividends
GNVR has not paid dividends in the last 2 fiscal years.
Who owns GNVR
- Insiders 31.28%
- Institutions 0.00%
- Public & others 68.72%
- Shares outstanding 36.4M
- Free float 25.0M
GNVR company profile
- Company name
- GNVR
- Ticker
- GNVR.US
- Exchange
- USA Stocks
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 5
- Fiscal year end
- September
- Address
- 1550 W Horizon Ridge Pkwy, Henderson, NV, United States, 89012
- Phone
- 715 903 6473
- Website
- genvor.com
About GNVR
Genvor Incorporated develops plant-based defense technology designed to help farmers achieve global food security. The company provides antimicrobial peptide technologies through the BioCypher platform by designing and validating minimum viable products and expanding its collaborations to include foliar application models, seed traits, and seed treatment platforms. The company has a strategic collaboration with Canlab International for the development, manufacturing, and commercialization of a portfolio of novel natural peptide candidates targeting weight management, anti-aging and longevity, tissue repair and regeneration, hair restoration, and hormonal optimization. Genvor Incorporated is based in Henderson, Nevada.
GNVR management
5- Mr. Chad Pawlak Sr.CEO & Director · born 1973
- Dr. Jesse M. Jaynes Ph.D.Chief Research Officer, Chief Scientific Officer & Director · born 1951
- Mr. Donald A. Kalkofen B.A.Chief Financial Officer · born 1964
- Dr. Windy Dean-Colomb M.D., Ph.D.Chief Clinical Officer
- Dr. George StavridesExecutive Vice President of Business Development & Commercialization